Stock listing

A2DQES Stock Price, News, Filings & Events — Thalia Therapeutics Plc

Selected listing: A2DQES · LSX · EUR · DE

A2DQES:LSX is the public stock listing for Thalia Therapeutics Plc. The company focuses on developing innovative therapies in the biopharmaceutical sector, aiming to address unmet medical needs. Recent news includes updates on their clinical trials and partnerships that may enhance their research capabilities. Investors can also find relevant filings and upcoming events that provide insights into the company's strategic direction and market positioning.

A2DQES:LSXEURDEUpdated August 1, 2026
Thalia Therapeutics Plc logo
Ticker
A2DQES:LSX
Asset type
Stock
Market cap
$22.4M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Thalia Therapeutics Plc A2DQES:LSX stock context

A2DQES:LSX is the public stock listing for Thalia Therapeutics Plc. The company focuses on developing innovative therapies in the biopharmaceutical sector, aiming to address unmet medical needs. Recent news includes updates on their clinical trials and partnerships that may enhance their research capabilities. Investors can also find relevant filings and upcoming events that provide insights into the company's strategic direction and market positioning.

Research Thalia Therapeutics Plc

Alternate listings